Effective for all members on August 1, 2017

Similar documents
Quarterly pharmacy formulary change notice

Effective for all members on November 1, 2017

Preventive health guidelines

The Medical Letter. on Drugs and Therapeutics

Comparison of representative topical corticosteroid preparations (classified according to the US system)

2018 Step Therapy (ST) Criteria

Medication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018

Step Therapy Criteria 2019

Drug Class Literature Scan: Topical Steroids

Step Therapy Requirements

Pharmacy Benefit Determination Policy

Michigan Pharmacy and Therapeutics Committee September 9, 2014 at 6:00 PM Kellogg Center, East Lansing, Michigan

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Eucrisa. Eucrisa (crisaborole) Description

Eucrisa. Eucrisa (crisaborole) Description

The safety and effectiveness of Dupixent in pediatric patients have not been established (1).

BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES

Comparison of representative topical corticosteroid preparations (classified according to the US system)

See Important Reminder at the end of this policy for important regulatory and legal information.

Step Therapy Requirements

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Part D Pharmacy. An Independent Licensee of the Blue Cross Blue Shield Association ( )

2018 Step Therapy Criteria (List of Step Therapy Criteria)

2018 Step Therapy Criteria (List of Step Therapy Criteria)

High-Cost Drug Exclusions

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 3Q17 July August

Updates to your prescription benefits

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Dupixent (dupilumab)

Updates to your prescription benefits

Amerigroup Washington, Inc. to conduct postservice reviews of certain modifiers and services

2017 Formulary Changes Year to Date

See Important Reminder at the end of this policy for important regulatory and legal information.

Connecticut Medicaid P&T Meeting Minutes December 2, 2010

Calgary Long Term Care Formulary

Children s Hospital Of Wisconsin

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

Topical Immunomodulators

Drugs That Require Step Therapy (ST)

High-Cost Drug Exclusions

Pharmacologic Treatment of Atopic Dermatitis

Calgary Long Term Care Formulary

Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD)

Drugs That Require Step Therapy (ST)

Drugs That Require Step Therapy (ST)

BlueLink TPA FlexRx Updates

Conversion from lantus to tresiba

Step Therapy Criteria (Criteria for Step Therapy-2 [ST-2] Drugs)

2018 Step Therapy (ST) Criteria

Texas Prior Authorization Program Clinical Edit Criteria

TABLE OF CONTENTS (Click on a link below to view the section.)

LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION

San Francisco Health Plan (SFHP)

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

2017 Step Therapy (ST) Criteria

Clinical Policy: Dupilumab (Dupixent) Reference Number: ERX.SPA.49 Effective Date:

Quarterly pharmacy formulary change notice

Step Therapy Medications

TABLE OF CONTENTS (Click on a link below to view the section.)

PHARMA-MEDIC SERVICES INC. POLICY MANUAL

Quarterly pharmacy formulary change notice

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Texas Prior Authorization Program Clinical Edit Criteria

Quarterly pharmacy formulary change notice

Quarterly Pharmacy Formulary Change Notice

WellCare s South Carolina Preferred Drug List Update

Quarterly pharmacy formulary change notice

Preventive health guidelines

Drug Formulary Update, April 2017 Commercial and State Programs

84:00. Skin and Mucous Membrane Agents. 84:00 Skin and Mucous Membrane Agents

Medication Therapy Management program

ALLERGIC RHINITIS-NASAL

Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices

Kentucky Pharmacy and Therapeutics Advisory Committee meeting minutes Triton Park Blvd., Louisville, KY April 26, p.m.-3 p.m.

Insulin Prior Authorization with optional Quantity Limit Program Summary

Quarterly pharmacy formulary change notice

2015 Medicare Step Therapy Criteria. Last Modified: 12/31/2014 Last Submitted to CMS: 10/29/2014

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

Health Partners Medicare Prime 2019 Formulary Changes

Sunderland Diabetes Network - Recommendations for safe prescribing of insulin.

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

See Important Reminder at the end of this policy for important regulatory and legal information.

Clinical pharmacology review for primary health care providers: II. Steroids

Drug Effectiveness Review Project Summary Report Long acting Insulins

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

Aetna Better Health of Illinois Medicaid Formulary Updates

High-Cost Drug Exclusions

Objectives. Navigating New Insulins. Disclosures. Diabetes: The Stats. Normal Insulin Release Individuals without diabetes. History of Insulin 5/23/17

TABLE OF CONTENTS (Click on a link below to view the section.)

Sunderland Diabetes Network - Recommendations for safe prescribing of insulin.

HEALTH SHARE/PROVIDENCE (OHP)

2019 Formulary Update

Prescription benefit updates Large group

Transcription:

August 2017 Pharmacy Formulary Change Notice BlueChoice HealthPlan Medicaid is here to help you stay on top of your health care. We want to tell you about some upcoming changes to your Preferred Drug List (PDL) as of August 1, 2017. Your PDL is a list of preferred drugs covered by BlueChoice HealthPlan Medicaid. A group of doctors and pharmacists check the PDL to make sure the drugs you re taking are safe and effective. Medication SPIRIVA 18 MCG CP-HANDIHALER DIFFERIN 0.1% GEL (OTC PRODUCT) (BRAND ONLY) COUMADIN 1 MG TABLET COUMADIN 2 MG TABLET COUMADIN 2.5 MG TABLET COUMADIN 3 MG TABLET COUMADIN 4 MG TABLET COUMADIN 5 MG TABLET COUMADIN 6 MG TABLET COUMADIN 7.5 MG TABLET COUMADIN 10 MG TABLET EQUETRO 100 MG CAPSULE EQUETRO 200 MG CAPSULE EQUETRO 300 MG CAPSULE LITHIUM 8 MEQ/5 ML SOLUTION LITHIUM 8 MEQ/5 ML SOLUTION TOUJEO SOLOSTAR 300 UNITS/ML Effective for all members on August 1, 2017 Changes WITH STEP THERAPY WITH PRIOR AUTHORIZATION (PA) ADD QUANTITY LIMIT (QL)* 15 ML PER 30 DAYS Your doctor may change it to one of these preferred drugs: SPIRIVA RESPIMAT 2.5 MCG INHALER SPIRIVA RESPIMAT 1.25 MCG INHALER WARFARIN TABLET JANTOVEN TABLET www.bluechoicescmedicaid.com BlueChoice HealthPlan is an independent licensee of the Blue Cross and Blue Shield Association. BlueChoice HealthPlan has contracted with Amerigroup Partnership Plan, LLC, an independent company, for services to support administration of Healthy Connections. WEBMBSC-0173-17 8/17

HUMULIN R 500 UNITS/ML VIAL HUMULIN R 500 UNITS/ML KWIKPEN NOVOLOG 100 UNIT/ML VIAL NOVOLOG 100 UNITS/ML FLEXPEN NOVOLOG 100 UNIT/ML CARTRIDGE LANTUS 100 UNITS/ML VIAL BASAGLAR 100 UNIT/ML KWIKPEN LANTUS SOLOSTAR 100 UNITS/ML HUMALOG 100 UNITS/ML VIAL HUMALOG 100 UNITS/ML KWIKPEN HUMALOG 200 UNITS/ML KWIKPEN HUMALOG 100 UNITS/ML CARTRIDGE LEVEMIR 100 UNITS/ML VIAL LEVEMIR FLEXTOUCH 100 UNITS/ML HUMULIN R 100 UNITS/ML VIAL NOVOLIN R 100 UNITS/ML VIAL RELION NOVOLIN R 100 UNIT/ML HUMULIN N 100 UNITS/ML VIAL NOVOLIN N 100 UNITS/ML VIAL RELION NOVOLIN N 100 UNIT/ML HUMULIN N 100 UNITS/ML KWIKPEN NOVOLOG MIX 70-30 VIAL NOVOLOG MIX 70-30 FLEXPEN SYRN HUMALOG MIX 75-25 VIAL HUMALOG MIX 50-50 VIAL HUMALOG MIX 75-25 KWIKPEN HUMALOG MIX 50-50 KWIKPEN HUMULIN 70-30 VIAL NOVOLIN 70-30 100 UNIT/ML VIAL RELION NOVOLIN 70-30 VIAL HUMULIN 70/30 KWIKPEN AFREZZA 90-4 UNIT AFREZZA 90-8 UNIT HYDROXYPROGESTERONE 1.25 G/5ML MAKENA 1;250 MG/5 ML VIAL MAKENA 250 MG/ML VIAL NALOXONE 0.4 MG/ML VIAL NALOXONE 4 MG/10 ML VIAL BD LUER-LOK SYRINGE 1ML 20GX1' LIDOCAINE 5% LIDOCAINE HCL 4% SOLUTION LIDOCAINE 2% VISCOUS SOLN LIDOCAINE HCL 4% SOLUTION 21ML PER 30 DAYS 30ML PER 30 DAYS 6 BOXES PER 30 DAYS 4 BOXES PER 30 DAYS WITH PA 5GMS PER DAY 10ML PER DAY

METRONIDAZOLE TOPICAL 1% GEL METRONIDAZOLE TOP 1% GEL PUMP HYDROCORTISONE 0.5 % TRIAMCINOLONE ACETONIDE 0.5 % TRIAMCINOLONE ACETONIDE 0.5 % ALCLOMETASONE DIPROPIONATE 0.05 % ALCLOMETASONE DIPROPIONATE 0.05 % HYDROCORTISONE BUTYRATE 0.1 % LOCOID 0.1 % HYDROCORTISONE BUTYRATE 0.1 % LOCOID LIPO 0.1 % SOLUTION, NON-ORAL CORMAX 0.05 % SOLUTION, NON-ORAL HALOBETASOL PROPIONATE 0.05 % ULTRAVATE 0.05 % HALOBETASOL PROPIONATE 0.05 % ULTRAVATE 0.05 % AMCINONIDE 0.1 % AMCINONIDE 0.1 % DESONIDE 0.05 % DESOWEN 0.05 % TRIDESILON 0.05 % DESONIDE 0.05 % LOTION (ML) DESOWEN 0.05 % LOTION (ML) DESONIDE 0.05 % DESOXIMETASONE 0.25 % TOPICORT 0.25 % DESOXIMETASONE 0.05 % GEL TOPICORT 0.05 % GEL DESOXIMETASONE 0.25 % TOPICORT 0.25 % DIFLORASONE DIACETATE 0.05 % PSORCON 0.05 % DIFLORASONE DIACETATE 0.05 % APEXICON E 0.05 % CUTIVATE 0.05 % 30GMS PER 30 DAYS 45GMS PER 30 DAYS 50GMS PER 30 DAYS 60GMS PER 30 DAYS

FLUTICASONE PROPIONATE 0.05 % FLUTICASONE PROPIONATE 0.005 % HALOG 0.1 % HALOG 0.1 % PANDEL 0.1 % CLOCORTOLONE PIVALATE 0.1 % CLODERM 0.1 % DERMATOP 0.1 % PREDNICARBATE 0.1 % DERMATOP 0.1 % PREDNICARBATE 0.1 % FOAM OLUX 0.05 % FOAM BETAMETHASONE DIPROPIONATE 0.05 % BETAMETHASONE DIPROPIONATE 0.05 % LOTION (ML) BETAMETHASONE DIPROPIONATE 0.05 % BETAMETHASONE VALERATE 0.1 % BETAMETHASONE VALERATE 0.1 % LOTION (ML) BETAMETHASONE VALERATE 0.1 % TEMOVATE 0.05 % TEMOVATE 0.05 % CLOBETASOL E 0.05 % FLUOCINOLONE ACETONIDE 0.01 % SOLUTION, NON-ORAL SYNALAR 0.01 % SOLUTION, NON-ORAL FLUOCINOLONE ACETONIDE 0.01 % FLUOCINOLONE ACETONIDE 0.025 % 80GMS PER 30 DAYS 90GMS PER 30 DAYS 100GMS PER 30 DAYS 120GMS PER 30 DAYS

SYNALAR 0.025 % FLUOCINOLONE ACETONIDE 0.025 % SYNALAR 0.025 % CAPEX SHAMPOO 0.01 % SHAMPOO FLUOCINONIDE 0.05 % FLUOCINONIDE 0.1 % VANOS 0.1 % HYDROCORTISONE VALERATE 0.2 % HYDROCORTISONE VALERATE 0.2 % FLUOCINONIDE 0.05 % SOLUTION, NON-ORAL FLUOCINONIDE 0.05 % GEL FLUOCINONIDE 0.05 % TRIANEX 0.05 % TRIAMCINOLONE ACETONIDE 0.025 % TRIAMCINOLONE ACETONIDE 0.1 % TRIDERM 0.1 % TRIAMCINOLONE ACETONIDE 0.025 % TRIAMCINOLONE ACETONIDE 0.1 % PREMARIN VAGINAL 180GMS PER 30 DAYS 240GMS PER 30 DAYS 430GMS PER 30 DAYS 454 GMS PER 30 DAYS WITH STEP THERAPY YUVAFEM 10 MCG VAGINAL INSERT YUVAFEM 10 MCG VAGINAL INSERT (BRAND ONLY) ELIXOPHYLLIN 80 MG/15 ML ELIX (BRAND ONLY) THEO-24 ER 100 MG CAPSULE THEO-24 ER 200 MG CAPSULE THEO-24 ER 300 MG CAPSULE THEO-24 ER 400 MG CAPSULE THEOPHYLLINE ER 400 MG TABLET THEOPHYLLINE ER 600 MG TABLET THEOPHYLLINE 80 MG/15 ML SOLN THEOPHYLLINE ER TABLETS

What does this mean for you? Some medications you take may no longer be preferred. You ll need approval from us to continue to get these medications. What should I do if I use a nonpreferred drug? Talk with your doctor to see if you can change to the new preferred drug. If your doctor says you can take the new preferred drug, ask him or her to write a new prescription for you. You and your doctor have the final say in your care. Things to remember: This doesn t change which pharmacy you go to or where you get your care. If your doctor writes a prescription for or says you need to keep using a nonpreferred drug, he or she will need to get approval from BlueChoice HealthPlan Medicaid first by calling 1-866-781-5094 (TTY 1-866-773-9634). Your health is important to us that s why we have our experienced team of doctors and pharmacists regularly review this list to keep you safe and healthy. Questions? Call us at the Customer Care Center at 1-866-781-5094 (TTY 1-866-773-9634) Monday through Friday from 8 a.m. to 6 p.m. Do you need help with your health care, talking with us, or reading what we send you? We provide our materials in other languages and formats at no cost to you. Call us toll free at 1-866-781-5094 (TTY 1-866-773-9634). Necesita ayuda con su cuidado de la salud, para hablar con nosotros o leer lo que le enviamos? Proporcionamos nuestros materiales en otros idiomas y formatos sin costo alguno para usted. Llámenos a la línea gratuita al 1-866-781-5094 (TTY 1-866-773-9634). هل تحتاج إلى مساعدة في رعايتك الصحية أو في التحد معنا أو قراءة ما نقوم بإرساله إليك نحن نقدم المواد الخاصة بنا بلغات وتنسيقات أخرى بدون تكلفة عليك. اتصل بنا على الرقم المجاني 1-866-781-5094 -1-866-773 (TTY.9634)